-
Enhancing Fc-mediated effector functions of monoclonal antibodies: The example of HexaBodies
van der Horst, H. J. & Mutis, T., Nov 2024, In: Immunological reviews. 328, 1, p. 456-465 10 p.Research output: Contribution to journal › Review article* › Academic › peer-review
-
Moving cancer therapy forward: Engineered antibodies for the treatment of B-cell malignancies
van der Horst, H. J., 2 Nov 2021, Amsterdam: s.n.. 204 p.Research output: PhD thesis › Thesis, fully internal
-
Duobody-CD3xCD20 Induces Potent Anti-Tumor Activity in Malignant Lymph Node B Cells from Patients with DLBCL, FL and MCL Ex Vivo, Irrespective of Prior Treatment with CD20 Monoclonal Antibodies
Van der Horst, H. J., de Jonge, A. V., Hiemstra, I. H., Gelderloos, A. T., Berry, D. R., Hijmering, N. J., de Jong, D., Chamuleau, M. E. D., Zweegman, S., Breij, E. C. W., Roemer, M. G. M. & Mutis, T., 13 Nov 2019, In: Blood. 134Research output: Contribution to journal › Meeting Abstract › Academic
- All publications
